enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO)

45 filings reported holding NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value as of Q2 2025.
enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5.08M shares of 19.1M outstanding shares and own 26.53% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (1.28M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (859K shares), VANGUARD GROUP INC (698K shares), Nantahala Capital Management, LLC (595K shares), Westside Investment Management, Inc. (280K shares), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) (241K shares), Universal- Beteiligungs- und Servicegesellschaft mbH (200K shares), GEODE CAPITAL MANAGEMENT, LLC (200K shares), JPMORGAN CHASE & CO (182K shares), and MORGAN STANLEY (75.3K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.